Peter Shields, MD

College

College of Medicine

Department/Division

Internal Medicine

Academic Title

Professor

Research Program

Cancer Control

Research Interest

Carcinoid Tumor

Dr. Shields is a medical oncologist with a focus on the treatment of lung cancer. His research interests are in prevention, with a focus on lung cancer and breast cancer. He studies the causes of cancer and develops biomarkers of cancer risk in order to develop more rational prevention methods and improve early detection of cancer.

Education and Background

Education

BA, University of Pennsylvania

Pennsylvania, PA (USA)
MD, Mount Sinai School of Medicine

New York, NY (USA)

Residencies

Internship, Internal Medicine

The George Washington University Hospital

Washington, DC
Residency, Internal Medicine

The George Washington University Hospital

Washington, DC

Fellowship

Clinical Fellowship, Hematology and Oncology, Joint Program

National Cancer Institute (NCI) and The George Washington University Hospital (Washington, DC) and the

Washington, D.C.

Office Location

D920 James Cancer Hospital & Solove Research Inst

460 W 10th Avenue, Columbus, Ohio 43210

614-366-5868

614-293-3132

shields.167@osu.edu

Publications

Comprehensive population-wide analysis of Lynch syndrome in Iceland reveals founder mutations in MSH6 and PMS2.

Haraldsdottir S, Rafnar T, Frankel WL, Einarsdottir S, Sigurdsson A, Hampel H, Snaebjornsson P, Masson G, Weng D, Arngrimsson R, Kehr B, Yilmaz A, Haraldsson S, Sulem P, Stefansson T, Shields PG, Sigurdsson F, Bekaii-Saab T, Moller PH, Steinarsdottir M, Alexiusdottir K, Hitchins M, Pritchard CC, de la Chapelle A, Jonasson JG, Goldberg RM, Stefansson K

Nat Commun 8 14755 05/03/2017
Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer.

Pearlman R, Frankel WL, Swanson B, Zhao W, Yilmaz A, Miller K, Bacher J, Bigley C, Nelsen L, Goodfellow PJ, Goldberg RM, Paskett E, Shields PG, Freudenheim JL, Stanich PP, Lattimer I, Arnold M, Liyanarachchi S, Kalady M, Heald B, Greenwood C, Paquette I, Prues M, Draper DJ, Lindeman C, Kuebler JP, Reynolds K, Brell JM, Shaper AA, Mahesh S, Buie N, Weeman K, Shine K, Haut M, Edwards J, Bastola S, Wickham K, Khanduja KS, Zacks R, Pritchard CC, Shirts BH, Jacobson A, Allen B, de la Chapelle A, Hampel H, Ohio Colorectal Cancer Prevention Initiative Study Group

JAMA Oncol 3 464-471 04/01/2017
Metabolomic profiles of current cigarette smokers.

Hsu PC, Lan RS, Brasky TM, Marian C, Cheema AK, Ressom HW, Loffredo CA, Pickworth WB, Shields PG

Mol Carcinog 56 594-606 02/01/2017
Reduced nicotine content cigarettes and use of alternative nicotine products: exploratory trial.

Hatsukami DK, Luo X, Dick L, Kangkum M, Allen SS, Murphy SE, Hecht SS, Shields P, al'Absi M, Hatsukami DK, Luo X, Dick L, Kangkum M, Allen SS, Murphy SE, Hecht SS, Shields PG, al'Absi M

Addiction 112 156-167 01/01/2017
Reduced nicotine content cigarettes and use of alternative nicotine products: exploratory trial.

Hatsukami DK, Luo X, Dick L, Kangkum M, Allen SS, Murphy SE, Hecht SS, Shields P, al'Absi M, Hatsukami DK, Luo X, Dick L, Kangkum M, Allen SS, Murphy SE, Hecht SS, Shields PG, al'Absi M

Addiction 112 156-167 01/01/2017
Menthol Smokers: Metabolomic Profiling and Smoking Behavior.

Hsu PC, Lan RS, Brasky TM, Marian C, Cheema AK, Ressom HW, Loffredo CA, Pickworth WB, Shields PG

Cancer Epidemiol Biomarkers Prev 26 51-60 01/01/2017
Discovery and replication of microRNAs for breast cancer risk using genome-wide profiling.

Taslim C, Weng DY, Brasky TM, Dumitrescu RG, Huang K, Kallakury BV, Krishnan S, Llanos AA, Marian C, McElroy J, Schneider SS, Spear SL, Troester MA, Freudenheim JL, Geyer S, Shields PG

Oncotarget 7 86457-86468 12/27/2016
Relationship between Overall Survival and Response or Progression-Free Survival in Advanced Non-Small Cell Lung Cancer Patients Treated with Anti-PD-1/PD-L1 Antibodies.

Shukuya T, Mori K, Amann JM, Bertino EM, Otterson GA, Shields PG, Morita S, Carbone DP

J Thorac Oncol 11 1927-1939 11/01/2016
Smoking Cessation, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.

Shields PG, Herbst RS, Arenberg D, Benowitz NL, Bierut L, Luckart JB, Cinciripini P, Collins B, David S, Davis J, Hitsman B, Hyland A, Lang M, Leischow S, Park ER, Purcell WT, Selzle J, Silber A, Spencer S, Tanvetyanon T, Tiep B, Tindle HA, Tucker-Seeley R, Urbanic J, Hooper MW, Weksler B, Whitlock CW, Wood DE, Burns J, Scavone J

J Natl Compr Canc Netw 14 1430-1468 11/01/2016
Persistent alterations of gene expression profiling of human peripheral blood mononuclear cells from smokers.

Weng DY, Chen J, Taslim C, Hsu PC, Marian C, David SP, Loffredo CA, Shields PG

Mol Carcinog 55 1424-37 10/01/2016
DNA methylation and breast tumor clinicopathological features: The Western New York Exposures and Breast Cancer (WEB) study.

Callahan CL, Wang Y, Marian C, Weng DY, Eng KH, Tao MH, Ambrosone CB, Nie J, Trevisan M, Smiraglia D, Edge SB, Shields PG, Freudenheim JL

Epigenetics 11 643-652 09/01/2016
Patients with colorectal cancer associated with Lynch syndrome and MLH1 promoter hypermethylation have similar prognoses.

Haraldsdottir S, Hampel H, Wu C, Weng DY, Shields PG, Frankel WL, Pan X, de la Chapelle A, Goldberg RM, Bekaii-Saab T

Genet Med 18 863-8 09/01/2016
Preference for Flavored Noncombustible Nicotine Products Among Smokers Motivated to Switch From Cigarettes.

Meier E, Isaksson Vogel R, O'Connor R, Severson H, Shields P, Hatsukami DK, Meier E, Isaksson Vogel R, O'Connor RJ, Severson HH, Shields PG, Hatsukami DK

Nicotine Tob Res 18 892-3 05/01/2016
Preference for Flavored Noncombustible Nicotine Products Among Smokers Motivated to Switch From Cigarettes.

Meier E, Isaksson Vogel R, O'Connor R, Severson H, Shields P, Hatsukami DK, Meier E, Isaksson Vogel R, O'Connor RJ, Severson HH, Shields PG, Hatsukami DK

Nicotine Tob Res 18 892-3 05/01/2016
Chemical and toxicological characteristics of conventional and low-TSNA moist snuff tobacco products.

Song MA, Marian C, Brasky TM, Reisinger S, Djordjevic M, Shields PG

Toxicol Lett 245 68-77 03/14/2016
Genetic variation in one-carbon metabolism in relation to genome-wide DNA methylation in breast tissue from heathy women.

Song MA, Brasky TM, Marian C, Weng DY, Taslim C, Llanos AA, Dumitrescu RG, Liu Z, Mason JB, Spear SL, Kallakury BV, Freudenheim JL, Shields PG

Carcinogenesis in press 03/09/2016
Single-Nucleotide Polymorphisms and Markers of Oxidative Stress in Healthy Women.

Minlikeeva AN, Browne RW, Ochs-Balcom HM, Marian C, Shields PG, Trevisan M, Krishnan S, Modali R, Seddon M, Lehman T, Freudenheim JL

PLoS One 11 e0156450 01/01/2016
Associations of intakes of magnesium and calcium and survival among women with breast cancer: results from Western New York Exposures and Breast Cancer (WEB) Study.

Tao MH, Dai Q, Millen AE, Nie J, Edge SB, Trevisan M, Shields PG, Freudenheim JL

Am J Cancer Res 6 105-13 01/01/2016
Associations of erythrocyte ?-3 fatty acids with biomarkers of ?-3 fatty acids and inflammation in breast tissue.

Roy S, Brasky TM, Belury MA, Krishnan S, Cole RM, Marian C, Yee LD, Llanos AA, Freudenheim JL, Shields PG

Int J Cancer 137 2934-46 12/15/2015
Adiposity is associated with p53 gene mutations in breast cancer.

Ochs-Balcom HM, Marian C, Nie J, Brasky TM, Goerlitz DS, Trevisan M, Edge SB, Winston J, Berry DL, Kallakury BV, Freudenheim JL, Shields PG

Breast Cancer Res Treat 153 635-45 10/01/2015
Know Your Value: Negotiation Skill Development for Junior Investigators in the Academic Environment--A Report from the American Society of Preventive Oncology's Junior Members Interest Group.

Burton-Chase AM, Swartz MC, Silvera SA, Basen-Engquist K, Fletcher FE, Shields PG

Cancer Epidemiol Biomarkers Prev 24 1144-8 07/01/2015
Telomere length variation: A potential new telomere biomarker for lung cancer risk.

Sun B, Wang Y, Kota K, Shi Y, Motlak S, Makambi K, Loffredo CA, Shields PG, Yang Q, Harris CC, Zheng YL

Lung Cancer 88 297-303 06/01/2015
New NCCN Guidelines: Smoking Cessation for Patients With Cancer.

Shields PG

J Natl Compr Canc Netw 13 643-5 05/01/2015
Providing a Science Base for the Evaluation of Tobacco Products.

Berman ML, Connolly G, Cummings KM, Djordjevic MV, Hatsukami DK, Henningfield JE, Myers M, O'Connor RJ, Parascandola M, Rees V, Rice JM, Shields PG

Tob Regul Sci 1 76-93 04/01/2015
Electronic nicotine delivery systems: a policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology.

Brandon TH, Goniewicz ML, Hanna NH, Hatsukami DK, Herbst RS, Hobin JA, Ostroff JS, Shields PG, Toll BA, Tyne CA, Viswanath K, Warren GW

J Clin Oncol 33 952-63 03/10/2015
Electronic nicotine delivery systems: a policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology.

Brandon TH, Goniewicz ML, Hanna NH, Hatsukami DK, Herbst RS, Hobin JA, Ostroff JS, Shields PG, Toll BA, Tyne CA, Viswanath K, Warren GW

Clin Cancer Res 21 514-25 02/01/2015
Mortality among capacitor workers exposed to polychlorinated biphenyls (PCBs), a long-term update.

Kimbrough RD, Krouskas CA, Xu W, Shields PG

Int Arch Occup Environ Health 88 85-101 01/01/2015
Relationships among folate, alcohol consumption, gene variants in one-carbon metabolism and p16INK4a methylation and expression in healthy breast tissues.

Llanos AA, Dumitrescu RG, Brasky TM, Liu Z, Mason JB, Marian C, Makambi KH, Spear SL, Kallakury BV, Freudenheim JL, Shields PG, Llanos AA, Dumitrescu RG, Brasky TM, Liu Z, Mason JB, Marian C, Makambi KH, Spear SL, Kallakury BV, Freudenheim JL, Shields PG

Carcinogenesis 36 60-7 01/01/2015
Relationships among folate, alcohol consumption, gene variants in one-carbon metabolism and p16INK4a methylation and expression in healthy breast tissues.

Llanos AA, Dumitrescu RG, Brasky TM, Liu Z, Mason JB, Marian C, Makambi KH, Spear SL, Kallakury BV, Freudenheim JL, Shields PG, Llanos AA, Dumitrescu RG, Brasky TM, Liu Z, Mason JB, Marian C, Makambi KH, Spear SL, Kallakury BV, Freudenheim JL, Shields PG

Carcinogenesis 36 60-7 01/01/2015
Associations between genetic variation in one-carbon metabolism and LINE-1 DNA methylation in histologically normal breast tissues.

Llanos AA, Marian C, Brasky TM, Dumitrescu RG, Liu Z, Mason JB, Makambi KH, Spear SL, Kallakury BV, Freudenheim JL, Shields PG

Epigenetics 10 727-35 01/01/2015
Racial differences in genome-wide methylation profiling and gene expression in breast tissues from healthy women.

Song MA, Brasky TM, Marian C, Weng D, Taslim C, Dumitrescu RG, Llanos AA, Freudenheim JL, Shields PG, Song MA, Brasky TM, Marian C, Weng DY, Taslim C, Dumitrescu RG, Llanos AA, Freudenheim JL, Shields PG

Epigenetics 10 1177-87 01/01/2015
Racial differences in genome-wide methylation profiling and gene expression in breast tissues from healthy women.

Song MA, Brasky TM, Marian C, Weng D, Taslim C, Dumitrescu RG, Llanos AA, Freudenheim JL, Shields PG, Song MA, Brasky TM, Marian C, Weng DY, Taslim C, Dumitrescu RG, Llanos AA, Freudenheim JL, Shields PG

Epigenetics 10 1177-87 01/01/2015
Genetic variation in adipokine genes and associations with adiponectin and leptin concentrations in plasma and breast tissue.

Llanos AA, Brasky TM, Mathew J, Makambi KH, Marian C, Dumitrescu RG, Freudenheim JL, Shields PG

Cancer Epidemiol Biomarkers Prev 23 1559-68 08/01/2014
Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia.

Claus R, Lucas DM, Ruppert AS, Williams KE, Weng D, Patterson K, Zucknick M, Oakes CC, Rassenti LZ, Greaves AW, Geyer S, Wierda WG, Brown JR, Gribben JG, Barrientos JC, Rai KR, Kay NE, Kipps TJ, Shields P, Zhao W, Grever MR, Plass C, Byrd JC

Blood 124 42-8 07/03/2014
Noninvasive urinary metabolomic profiling identifies diagnostic and prognostic markers in lung cancer.

Mathé EA, Patterson AD, Haznadar M, Manna SK, Krausz KW, Bowman ED, Shields PG, Idle JR, Smith PB, Anami K, Kazandjian DG, Hatzakis E, Gonzalez FJ, Harris CC

Cancer Res 74 3259-70 06/15/2014
Future directions for postdoctoral training in cancer prevention: insights from a panel of experts.

Nelson DE, Faupel-Badger J, Phillips S, Belcher B, Chang S, Abrams DB, Kramer BS, White MC, O'Malley M, Varanasi AP, Fabian CJ, Wiest JS, Colditz GA, Hall K, Shields PG, Weitzel JN

Cancer Epidemiol Biomarkers Prev 23 679-83 04/01/2014
Genome-wide methylation patterns provide insight into differences in breast tumor biology between American women of African and European ancestry.

Ambrosone CB, Young AC, Sucheston LE, Wang D, Yan L, Liu S, Tang L, Hu Q, Freudenheim JL, Shields PG, Morrison CD, Demissie K, Higgins MJ

Oncotarget 5 237-48 01/15/2014
Association of prediagnostic physical activity with survival following breast cancer diagnosis: influence of TP53 mutation status.

Tao MH, Hainaut P, Marian C, Nie J, Ambrosone C, Edge SB, Trevisan M, Dorn J, Shields PG, Freudenheim JL

Cancer Causes Control 24 2177-86 12/01/2013
Pregnancy-related characteristics and breast cancer risk.

Brasky TM, Li Y, Jaworowicz DJ Jr, Potischman N, Ambrosone CB, Hutson AD, Nie J, Shields PG, Trevisan M, Rudra CB, Edge SB, Freudenheim JL

Cancer Causes Control 24 1675-85 09/01/2013
Behavioral and psychosocial responses to genomic testing for colorectal cancer risk.

Graves KD, Leventhal KG, Nusbaum R, Salehizadeh Y, Hooker GW, Peshkin BN, Butrick M, Tuong W, Mathew J, Goerlitz D, Fishman MB, Shields PG, Schwartz MD

Genomics 102 123-30 08/01/2013
BRCA1 polymorphisms and breast cancer epidemiology in the Western New York exposures and breast cancer (WEB) study.

Trevisan M, Edge SB, Kanaan Y, Freudenheim JL, Shields PG, Ricks-Santi LJ, Nie J, Marian C, Ochs-Balcom HM

Genet Epidemiol 37 504-11 07/01/2013
Bayesian sensitivity analysis methods to evaluate bias due to misclassification and missing data using informative priors and external validation data.

Luta G, Ford MB, Bondy M, Shields PG, Stamey JD

Cancer Epidemiol 37 121-6 04/01/2013
Plasma IGF-1 and IGFBP-3 may be imprecise surrogates for breast concentrations: an analysis of healthy women.

Llanos AA, Brasky TM, Dumitrescu RG, Marian C, Makambi KH, Kallakury BV, Spear SL, Perry DJ, Convit RJ, Platek ME, Adams-Campbell LL, Freudenheim JL, Shields PG

Breast Cancer Res Treat 138 571-9 04/01/2013
Clustering of place of birth for women with breast cancer: differences by tumor characteristics.

Han D, Nie J, Bonner MR, Ambrosone C, Marian C, Shields P, Trevisan M, Edge SB, Freudenheim JL

Cancer Causes Control 24 587-94 03/01/2013
Translational Genomic Research: Protocol Development and Initial Outcomes following SNP Testing for Colon Cancer Risk.

Nusbaum R, Leventhal KG, Hooker GW, Peshkin BN, Butrick M, Salehizadeh Y, Tuong W, Eggly S, Mathew J, Goerlitz D, Shields PG, Schwartz MD, Graves KD

Transl Behav Med 3 17-29 03/01/2013
Feasibility of identifying the tobacco-related global metabolome in blood by UPLC-QTOF-MS.

Hsu PC, Zhou B, Zhao Y, Ressom HW, Cheema AK, Pickworth W, Shields PG

J Proteome Res 12 679-91 02/01/2013
Adipokines in plasma and breast tissues: associations with breast cancer risk factors.

Llanos AA, Dumitrescu RG, Marian C, Makambi KH, Spear SL, Kallakury BV, Perry DJ, Convit RJ, Platek ME, Millen AE, Adams-Campbell LL, Freudenheim JL, Shields PG

Cancer Epidemiol Biomarkers Prev 21 1745-55 10/01/2012